Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | TYMS | P04818 | 8/20 | 0.58 |
| ▸ | PARP1 | P09874 | 1/20 | 0.56 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | ACVR1 | Q04771 | 2/20 | 0.48 |
| ▸ | PARG | Q86W56 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27496027 | 0.89 | KDM4E (0.55) | KDM4EHSD17B10LMNATYMSPARP1 | |
| SCHEMBL9514599 | 0.87 | KDM4E (0.59) | KDM4EHSD17B10LMNATYMSPARP1 | |
| SCHEMBL6446127 | 0.87 | TYMS (0.68) | KDM4EHSD17B10LMNATYMSPARP1 | |
| SCHEMBL27812566 | 0.83 | KDM4E (0.55) | KDM4EHSD17B10LMNATYMSPARP1 | |
| SCHEMBL9810830 | 0.81 | TNKS2 (0.60) | KDM4ELMNATYMSPARP1TNKS2 | |
| SCHEMBL9555707 | 0.81 | KDM4E (0.52) | KDM4EHSD17B10LMNATYMSPARP1 | |
| SCHEMBL28932180 | 0.81 | TYMS (0.56) | TYMS | |
| SCHEMBL29900526 | 0.80 | TYMS (0.72) | KDM4EHSD17B10LMNATYMSPARP1 | |
| SCHEMBL3115005 | 0.80 | TYMS (0.72) | KDM4EHSD17B10LMNATYMSPARP1 | |
| SCHEMBL29535139 | 0.80 | KDM4E (0.66) | KDM4EHSD17B10LMNATYMSPARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119161331-A | Preparation method of degradation impurities in raltitrexed preparation | 浙江皓格药业有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-115785081-A | Preparation method of raltitrexed | 连云港润众制药有限公司 | 2023-03-14 | — | — | CN | claimed |
| CN-110551114-A | Preparation method of raltitrexed | LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD | 2019-12-10 | — | — | CN | claimed |
| CN-106802684-B | Purple sweet potato pears compound fruit vinegar fermentation monitoring system and its method of work based on MAS | 徐州工程学院 | 2018-05-22 | — | — | CN | claimed |
| CN-1223593-C | Preparation of Leiliqusai | LUNAN PHARM CO LTD (CN) | 2005-10-19 | — | — | CN | claimed |
| CN-119161331-A | Preparation method of degradation impurities in raltitrexed preparation | 浙江皓格药业有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-115785081-A | Preparation method of raltitrexed | 连云港润众制药有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-111995588-B | Synthesis method of 6- (dibromomethyl) -2-methyl quinazoline-4 (3H) -ketone | 宏冠生物药业有限公司 | 2022-04-22 | — | — | CN | disclosed |
| CN-106957296-B | 5- ((alkoxymethylene) amino) thienyl-2-formyl) -L-glutamic acid dialkyl ester and preparation method thereof | 南京正大天晴制药有限公司 | 2022-03-08 | — | — | CN | disclosed |
| CN-111995588-A | Synthesis method of 6- (dibromomethyl) -2-methyl quinazoline-4 (3H) -ketone | 宏冠生物药业有限公司 | 2020-11-27 | — | — | CN | disclosed |
| CN-110551114-A | Preparation method of raltitrexed | LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD | 2019-12-10 | — | — | CN | disclosed |
| CN-106802684-B | Purple sweet potato pears compound fruit vinegar fermentation monitoring system and its method of work based on MAS | 徐州工程学院 | 2018-05-22 | — | — | CN | disclosed |
| WO-1992016512-A1 | ANTI-CANCER COMPOUNDS | BRITISH TECHNOLOGY GROUP PLC (GB) | 1992-10-01 | — | — | WO | disclosed |
| US-5089499-A | Anticarcinogenic agents; thymidylate synthetase inhibitors; antiallergens; psoriasis | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-02-18 | — | — | US | disclosed |
| US-5081124-A | Amino acid and polyamino acid derivatives, inhibitors of thymidylate synthetase | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-01-14 | — | — | US | disclosed |
| EP-0239362-B1 | ANTI-TUMOR AGENTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-12-04 | — | — | EP | disclosed |
| US-4992550-A | Thymidylate synthetase inhibitors | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-02-12 | — | — | US | disclosed |
| EP-0373891-A2 | Anti-tumour agents | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-06-20 | — | — | EP | disclosed |
| EP-0365763-A1 | Antiproliferative cyclic compounds | AGOURON PHARMACEUTICALS, INC. (US) | 1990-05-02 | — | — | EP | disclosed |
| EP-0239362-A2 | Anti-tumor agents | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-09-30 | — | — | EP | disclosed |